Avantor, Inc.

Supplier Financial Health Report

Overview

June 2024

USA

Incorporated Country

14,500

Number of Employees

A+

Credit Rating

1

Count of Funding Rounds

Avantor, Inc. is a prominent company based in the United States, known for providing essential products and services to a diverse range of industries, including biotechnology, electronics, industrial, life science, manufacturing, and pharmaceutical sectors. With a workforce of 14,500 dedicated professionals, Avantor is a significant player in these industries. The company's mission-critical offerings have earned it a strong reputation and an impressive credit rating of A+, accompanied by a credit score of 97 and a constant credit trend. Michael Stubblefield leads Avantor as its CEO.

Five-Year Financial Trend Analysis for Avantor, Inc.

CONSTANT

Credit Trend

35.84%

Total Balance Sheet Growth Rate

-9.20%

Total Debt Growth Rate

Avantor, Inc., a leading provider of mission-critical products and services to customers in the life sciences and applied materials industries, has shown a robust financial health over the past five years. The company's annual revenue trend has been on the rise, increasing from $5.86B in 2018 to $7.51B in 2022, representing a significant 28.10% growth. This trend is reflected in the balance sheet, which has grown from $9.91B in 2018 to $13.46B in 2022, a 35.84% increase.

The company's financial position is further strengthened by its strong credit rating of A+ and an excellent credit score of 97, which indicates a strong financial health and low credit risk. The credit trend has remained constant, which is a favorable sign. Avantor's cash position has also been on the rise, increasing from $184.7M in 2018 to $372.9M in 2022, a 101.89% change.

However, the company's total debt and liabilities have shown a decrease, dropping from $6.92B in 2018 to $6.29B in 2022, and from $9.1B in 2018 to $8.61B in 2022, respectively. This trend is a positive sign, as it indicates that the company is reducing its debt and liabilities. The stockholders equity has also shown a significant increase, rising from -$3.05B in 2018 to $4.86B in 2022, a 259.10% change.

The net income trend has also been positive, rising from -$145.3M in 2017 to $686.5M in 2022, a 572.47% change. The EBITDA trend has followed a similar pattern, increasing from $814.6M in 2018 to $1.52B in 2022, an 86.89% change. The net operating cash flow trend has also shown a significant increase, rising from -$167.5M in 2017 to $843.6M in 2022, a 603.64% change. The free cash flow trend has followed a similar trend, increasing from $162.8M in 2018 to $710.2M in 2022, a 336.24% change.

Avantor's revenue is diversified across various countries, with Germany being the largest market, accounting for 12.03% of the revenue in the most recent period. The United Kingdom, France, Italy, and the Russian Federation are also significant markets for the company.

Despite the positive financial trends, it is important to note that there is limited information available about the company's funding history, with only one funding round recorded and no total funding amount or number of investments or exits provided. This makes it difficult to assess the company's growth trajectory and investment activity. Overall, Avantor's financial health is strong, with a robust revenue trend, a strong credit position, and increasing cash and equity positions.

Financial Health Risk Assessment for Avantor, Inc.

LOW

Credit Risk

LOW

Bankruptcy Risk

MEDIUM

Financial Health Risk

Avantor, Inc., a leading provider of mission-critical products and services to the life sciences and applied materials industries, has demonstrated a robust financial health over the past five years. The company's annual revenue has grown significantly, from $5.86 billion in 2018 to $7.51 billion in 2022, representing a 28.10% increase. This trend is reflected in the balance sheet, which has grown from $9.91 billion in 2018 to $13.46 billion in 2022, a 35.84% increase. Avantor's strong financial position is further evidenced by its credit rating of A+ and an excellent credit score of 97, indicating a strong financial health and low credit risk.

However, there are areas of concern that merit further investigation. The company's quick ratio of 0.96 suggests that it may not be able to cover its short-term obligations with its most liquid assets. This could potentially limit the company's ability to respond to unexpected financial challenges. Additionally, the debt-to-equity ratio of 1.77 indicates that Avantor is using more debt than equity to finance its growth. While the debt ratio of 0.47 is relatively low, a higher debt-to-equity ratio could increase financial risk for the company.

Another concern is the limited information available about Avantor's funding history. With only one funding round recorded and no total funding amount or number of investments or exits provided, it is difficult to assess the company's growth trajectory and investment activity. This lack of transparency could be a concern for investors looking to make informed decisions about the company's financial health.

Overall, while Avantor's financial health is generally strong, these areas of concern merit further investigation to ensure the company's long-term financial stability. It is recommended that investors closely monitor the company's liquidity position and consider the implications of its debt-to-equity ratio. Additionally, more information about Avantor's funding history would be beneficial for a complete assessment of its financial health.

List of UEIs for Avantor, Inc.

H97MYELNTF24, CAJZL4M9RPN8, LUFQLD1DLSA3, USTWWR6FSRX7, J6CNECEBTK23, K98CN277XJE6

ABOUT SUPPLIER FINANCIAL HEALTH REPORTS

Ark provides definitive, consolidated analyses of every vendor, subcontractor, supplier, grant awardee, non-profit, and investment organization in the national security and defense sectors. Supplier financial health reports are AI-assisted analyses of the current health and stability of an organization, as well as the trends, trajectory, and risk indicators that partners and stakeholders need to know about.

ABOUT ARK.AI

The Ark is the only software platform purpose-built for Defense Acquisition that leverages authoritative commercial data and AI-enabled Applications designed to solve Acquisition challenges. With the Ark, analysts and decision-makers gain the ability to manage Acquisition programs proactively, allowing them to unwind the legacy complexity and effectively field modern warfighting systems that compete with China.

The Leading Defense Acquisition Software.

Army SealASN SealCyber SealDLA SealDOD SealNavy SealAirforce SealDISA Seal

OUR APPLICATIONS

AI-enabled Applications within The Ark reflect standard workflows across the Defense Acquisition Process. From Science & Technology to Modernization, these Applications allow for the execution of rapid, efficient, data-informed decisions, standardized reporting, and efficient workflow management. The Ark enables your team to transform Defense Acquisition into a strategic advantage.

Army Seal